Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the CAR T-Cell Immunotherapy industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Oxford BioMedica
Minerva Biotechnologies
Cellectis
Creative Biolabs
Gilead
Celgene
Pfizer
Mustang Bio
CARsgen Therapeutics
Aurora Biopharma
Xyphos
AbbVie
Bellicum
Adaptimmune
Novartis
Kite Pharma
Ziopharm Oncology
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Monotherapy
Combination Therapy
Application:
Hematologic Malignancies
Solid Malignancies
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 CAR T-Cell Immunotherapy Industry Overview
-
1.1.1 CAR T-Cell Immunotherapy Market Scope and Market Segments
-
1.1.2 CAR T-Cell Immunotherapy Industry Characteristics
-
1.1.3 Global and China CAR T-Cell Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China CAR T-Cell Immunotherapy Production Value and Growth Rate (2017-2028)
-
1.2 Global CAR T-Cell Immunotherapy Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Monotherapy
-
1.2.2 Combination Therapy
-
1.3 Global CAR T-Cell Immunotherapy Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Hematologic Malignancies
-
1.3.2 Solid Malignancies
-
1.4 Market Analysis by Region
-
1.4.1 North America CAR T-Cell Immunotherapy Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe CAR T-Cell Immunotherapy Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC CAR T-Cell Immunotherapy Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa CAR T-Cell Immunotherapy Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global CAR T-Cell Immunotherapy Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global CAR T-Cell Immunotherapy Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China CAR T-Cell Immunotherapy Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China CAR T-Cell Immunotherapy Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global CAR T-Cell Immunotherapy Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 CAR T-Cell Immunotherapy Industry Porter's Five Forces Model Analysis
-
2.2.3 CAR T-Cell Immunotherapy Industry PEST Analysis
-
2.3 CAR T-Cell Immunotherapy Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 CAR T-Cell Immunotherapy Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on CAR T-Cell Immunotherapy Industry
Chapter 3 Global and China CAR T-Cell Immunotherapy Market, by Manufacturer
-
3.1 Global and China CAR T-Cell Immunotherapy Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China CAR T-Cell Immunotherapy Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China CAR T-Cell Immunotherapy Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China CAR T-Cell Immunotherapy Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China CAR T-Cell Immunotherapy Market Top 3 Players
Chapter 4 Global and China CAR T-Cell Immunotherapy Market, by Type (2017-2028)
-
4.1 CAR T-Cell Immunotherapy Market Trend, by Type
-
4.2 Global CAR T-Cell Immunotherapy Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global CAR T-Cell Immunotherapy Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global CAR T-Cell Immunotherapy Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global CAR T-Cell Immunotherapy Price Trend, by Type (2017-2028)
-
4.3 China CAR T-Cell Immunotherapy Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China CAR T-Cell Immunotherapy Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China CAR T-Cell Immunotherapy Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China CAR T-Cell Immunotherapy Price Trend, by Type (2017-2028)
Chapter 5 Global and China CAR T-Cell Immunotherapy Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global CAR T-Cell Immunotherapy Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global CAR T-Cell Immunotherapy Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global CAR T-Cell Immunotherapy Sales Value and Market Share, by Application (2017-2028)
-
5.3 China CAR T-Cell Immunotherapy Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China CAR T-Cell Immunotherapy Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China CAR T-Cell Immunotherapy Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global CAR T-Cell Immunotherapy Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China CAR T-Cell Immunotherapy Production, Import, Consumption and Export (2017-2022)
-
6.2 North America CAR T-Cell Immunotherapy Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe CAR T-Cell Immunotherapy Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC CAR T-Cell Immunotherapy Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa CAR T-Cell Immunotherapy Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America CAR T-Cell Immunotherapy Market Analysis
-
7.1 North America CAR T-Cell Immunotherapy Market, by Type
-
7.2 North America CAR T-Cell Immunotherapy Market, by Application
-
7.3 North America CAR T-Cell Immunotherapy Market Analysis and Forecast, by Country
-
7.3.1 United States CAR T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada CAR T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico CAR T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe CAR T-Cell Immunotherapy Market Analysis
-
8.1 Europe CAR T-Cell Immunotherapy Market, by Type
-
8.2 Europe CAR T-Cell Immunotherapy Market, by Application
-
8.3 Europe CAR T-Cell Immunotherapy Market Analysis and Forecast, by Country
-
8.3.1 Germany CAR T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK CAR T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France CAR T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy CAR T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries CAR T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain CAR T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium CAR T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland CAR T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia CAR T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey CAR T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC CAR T-Cell Immunotherapy Market Analysis
-
9.1 APAC CAR T-Cell Immunotherapy Market, by Type
-
9.2 APAC CAR T-Cell Immunotherapy Market, by Application
-
9.3 APAC CAR T-Cell Immunotherapy Market Analysis and Forecast, by Country
-
9.3.1 China CAR T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan CAR T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand CAR T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India CAR T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries CAR T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea CAR T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa CAR T-Cell Immunotherapy Market Analysis
-
10.1 Latin America, Middle East and Africa CAR T-Cell Immunotherapy Market, by Type
-
10.2 Latin America, Middle East and Africa CAR T-Cell Immunotherapy Market, by Application
-
10.3 Latin America, Middle East and Africa CAR T-Cell Immunotherapy Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries CAR T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil CAR T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria CAR T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa CAR T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina CAR T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China CAR T-Cell Immunotherapy Company Profiles
-
11.1 Oxford BioMedica
-
11.1.1 Oxford BioMedica Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Oxford BioMedica CAR T-Cell Immunotherapy Product Profiles, Application and Specification
-
11.1.3 Oxford BioMedica CAR T-Cell Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Minerva Biotechnologies
-
11.2.1 Minerva Biotechnologies Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Minerva Biotechnologies CAR T-Cell Immunotherapy Product Profiles, Application and Specification
-
11.2.3 Minerva Biotechnologies CAR T-Cell Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Cellectis
-
11.3.1 Cellectis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Cellectis CAR T-Cell Immunotherapy Product Profiles, Application and Specification
-
11.3.3 Cellectis CAR T-Cell Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Creative Biolabs
-
11.4.1 Creative Biolabs Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Creative Biolabs CAR T-Cell Immunotherapy Product Profiles, Application and Specification
-
11.4.3 Creative Biolabs CAR T-Cell Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Gilead
-
11.5.1 Gilead Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Gilead CAR T-Cell Immunotherapy Product Profiles, Application and Specification
-
11.5.3 Gilead CAR T-Cell Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Celgene
-
11.6.1 Celgene Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Celgene CAR T-Cell Immunotherapy Product Profiles, Application and Specification
-
11.6.3 Celgene CAR T-Cell Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 Pfizer
-
11.7.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 Pfizer CAR T-Cell Immunotherapy Product Profiles, Application and Specification
-
11.7.3 Pfizer CAR T-Cell Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 Mustang Bio
-
11.8.1 Mustang Bio Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 Mustang Bio CAR T-Cell Immunotherapy Product Profiles, Application and Specification
-
11.8.3 Mustang Bio CAR T-Cell Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 CARsgen Therapeutics
-
11.9.1 CARsgen Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 CARsgen Therapeutics CAR T-Cell Immunotherapy Product Profiles, Application and Specification
-
11.9.3 CARsgen Therapeutics CAR T-Cell Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.10 Aurora Biopharma
-
11.10.1 Aurora Biopharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.10.2 Aurora Biopharma CAR T-Cell Immunotherapy Product Profiles, Application and Specification
-
11.10.3 Aurora Biopharma CAR T-Cell Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.11 Xyphos
-
11.11.1 Xyphos Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.11.2 Xyphos CAR T-Cell Immunotherapy Product Profiles, Application and Specification
-
11.11.3 Xyphos CAR T-Cell Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.12 AbbVie
-
11.12.1 AbbVie Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.12.2 AbbVie CAR T-Cell Immunotherapy Product Profiles, Application and Specification
-
11.12.3 AbbVie CAR T-Cell Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.13 Bellicum
-
11.13.1 Bellicum Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.13.2 Bellicum CAR T-Cell Immunotherapy Product Profiles, Application and Specification
-
11.13.3 Bellicum CAR T-Cell Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.14 Adaptimmune
-
11.14.1 Adaptimmune Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.14.2 Adaptimmune CAR T-Cell Immunotherapy Product Profiles, Application and Specification
-
11.14.3 Adaptimmune CAR T-Cell Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.15 Novartis
-
11.15.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.15.2 Novartis CAR T-Cell Immunotherapy Product Profiles, Application and Specification
-
11.15.3 Novartis CAR T-Cell Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.16 Kite Pharma
-
11.16.1 Kite Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.16.2 Kite Pharma CAR T-Cell Immunotherapy Product Profiles, Application and Specification
-
11.16.3 Kite Pharma CAR T-Cell Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.17 Ziopharm Oncology
-
11.17.1 Ziopharm Oncology Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.17.2 Ziopharm Oncology CAR T-Cell Immunotherapy Product Profiles, Application and Specification
-
11.17.3 Ziopharm Oncology CAR T-Cell Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 CAR T-Cell Immunotherapy Industry Investment Prospect and Risk Assessment
-
12.1 CAR T-Cell Immunotherapy Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 CAR T-Cell Immunotherapy Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global CAR T-Cell Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure China CAR T-Cell Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Global CAR T-Cell Immunotherapy Production Value and Growth Rate (2017-2028)
-
Figure China CAR T-Cell Immunotherapy Production Value and Growth Rate (2017-2028)
-
Figure Global CAR T-Cell Immunotherapy Market Size and Growth Rate of Monotherapy (2017-2028)
-
Figure Global CAR T-Cell Immunotherapy Market Size and Growth Rate of Combination Therapy (2017-2028)
-
Figure Global CAR T-Cell Immunotherapy Market Size and Growth Rate of Hematologic Malignancies (2017-2028)
-
Figure Global CAR T-Cell Immunotherapy Market Size and Growth Rate of Solid Malignancies (2017-2028)
-
Figure North America CAR T-Cell Immunotherapy Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe CAR T-Cell Immunotherapy Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC CAR T-Cell Immunotherapy Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa CAR T-Cell Immunotherapy Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global CAR T-Cell Immunotherapy Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China CAR T-Cell Immunotherapy Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China CAR T-Cell Immunotherapy Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China CAR T-Cell Immunotherapy Sales Value, by Manufacturer (2021&2022)
-
Table Global and China CAR T-Cell Immunotherapy Market Share, by Manufacturer (2021&2022)
-
Figure Global and China CAR T-Cell Immunotherapy Market Share, by Manufacturer in 2021
-
Figure Global and China CAR T-Cell Immunotherapy Market Share, by Manufacturer in 2022
-
Table Global CAR T-Cell Immunotherapy Sales Volume, by Type (2017-2028)
-
Table Global CAR T-Cell Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Figure Global CAR T-Cell Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Table Global CAR T-Cell Immunotherapy Sales Value, by Type (2017-2028)
-
Table Global CAR T-Cell Immunotherapy Sales Value Share, by Type (2017-2028)
-
Figure Global CAR T-Cell Immunotherapy Price Trend, by Type (2017-2028)
-
Table China CAR T-Cell Immunotherapy Sales Volume, by Type (2017-2028)
-
Table China CAR T-Cell Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Figure China CAR T-Cell Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Table China CAR T-Cell Immunotherapy Sales Value, by Type (2017-2028)
-
Table China CAR T-Cell Immunotherapy Sales Value Share, by Type (2017-2028)
-
Figure China CAR T-Cell Immunotherapy Price Trend, by Type (2017-2028)
-
Table Global CAR T-Cell Immunotherapy Sales Volume, by Application (2017-2028)
-
Table Global CAR T-Cell Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Figure Global CAR T-Cell Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Table Global CAR T-Cell Immunotherapy Sales Value, by Application (2017-2028)
-
Table Global CAR T-Cell Immunotherapy Sales Value Share, by Application (2017-2028)
-
Figure Global CAR T-Cell Immunotherapy Sales Value Share, by Application (2017-2028)
-
Table China CAR T-Cell Immunotherapy Sales Volume, by Application (2017-2028)
-
Table China CAR T-Cell Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Figure China CAR T-Cell Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Table China CAR T-Cell Immunotherapy Sales Value, by Application (2017-2028)
-
Table China CAR T-Cell Immunotherapy Sales Value Share, by Application (2017-2028)
-
Figure China CAR T-Cell Immunotherapy Sales Value Share, by Application (2017-2028)
-
Figure China CAR T-Cell Immunotherapy Production, Import, Consumption and Export (2017-2022)
-
Figure North America CAR T-Cell Immunotherapy Production, Import, Consumption and Export (2017-2022)
-
Figure Europe CAR T-Cell Immunotherapy Production, Import, Consumption and Export (2017-2022)
-
Figure APAC CAR T-Cell Immunotherapy Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa CAR T-Cell Immunotherapy Production, Import, Consumption and Export (2017-2022)
-
Table North America CAR T-Cell Immunotherapy Sales Volume, by Type (2017-2028)
-
Table North America CAR T-Cell Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Figure North America CAR T-Cell Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Table North America CAR T-Cell Immunotherapy Sales Volume, by Application (2017-2028)
-
Table North America CAR T-Cell Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Figure North America CAR T-Cell Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Figure United States CAR T-Cell Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure United States CAR T-Cell Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Canada CAR T-Cell Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Canada CAR T-Cell Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Mexico CAR T-Cell Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico CAR T-Cell Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Table Europe CAR T-Cell Immunotherapy Sales Volume, by Type (2017-2028)
-
Table Europe CAR T-Cell Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Figure Europe CAR T-Cell Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Table Europe CAR T-Cell Immunotherapy Sales Volume, by Application (2017-2028)
-
Table Europe CAR T-Cell Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Figure Europe CAR T-Cell Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Figure Germany CAR T-Cell Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Germany CAR T-Cell Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure UK CAR T-Cell Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure UK CAR T-Cell Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure France CAR T-Cell Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure France CAR T-Cell Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Italy CAR T-Cell Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Italy CAR T-Cell Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries CAR T-Cell Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries CAR T-Cell Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Spain CAR T-Cell Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Spain CAR T-Cell Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Belgium CAR T-Cell Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium CAR T-Cell Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Poland CAR T-Cell Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Poland CAR T-Cell Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Russia CAR T-Cell Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Russia CAR T-Cell Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Turkey CAR T-Cell Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey CAR T-Cell Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Table APAC CAR T-Cell Immunotherapy Sales Volume, by Type (2017-2028)
-
Table APAC CAR T-Cell Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Figure APAC CAR T-Cell Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Table APAC CAR T-Cell Immunotherapy Sales Volume, by Application (2017-2028)
-
Table APAC CAR T-Cell Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Figure APAC CAR T-Cell Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Figure China CAR T-Cell Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure China CAR T-Cell Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Japan CAR T-Cell Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Japan CAR T-Cell Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand CAR T-Cell Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand CAR T-Cell Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure India CAR T-Cell Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure India CAR T-Cell Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries CAR T-Cell Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries CAR T-Cell Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure South Korea CAR T-Cell Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea CAR T-Cell Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa CAR T-Cell Immunotherapy Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa CAR T-Cell Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa CAR T-Cell Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa CAR T-Cell Immunotherapy Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa CAR T-Cell Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa CAR T-Cell Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries CAR T-Cell Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries CAR T-Cell Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Brazil CAR T-Cell Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil CAR T-Cell Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria CAR T-Cell Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria CAR T-Cell Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure South Africa CAR T-Cell Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa CAR T-Cell Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Argentina CAR T-Cell Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina CAR T-Cell Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Table Oxford BioMedica Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Oxford BioMedica Product Profiles, Application and Specification
-
Table Oxford BioMedica CAR T-Cell Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Minerva Biotechnologies Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Minerva Biotechnologies Product Profiles, Application and Specification
-
Table Minerva Biotechnologies CAR T-Cell Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Cellectis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Cellectis Product Profiles, Application and Specification
-
Table Cellectis CAR T-Cell Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Creative Biolabs Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Creative Biolabs Product Profiles, Application and Specification
-
Table Creative Biolabs CAR T-Cell Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Gilead Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Gilead Product Profiles, Application and Specification
-
Table Gilead CAR T-Cell Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Celgene Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Celgene Product Profiles, Application and Specification
-
Table Celgene CAR T-Cell Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Pfizer Product Profiles, Application and Specification
-
Table Pfizer CAR T-Cell Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Mustang Bio Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Mustang Bio Product Profiles, Application and Specification
-
Table Mustang Bio CAR T-Cell Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table CARsgen Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table CARsgen Therapeutics Product Profiles, Application and Specification
-
Table CARsgen Therapeutics CAR T-Cell Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Aurora Biopharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Aurora Biopharma Product Profiles, Application and Specification
-
Table Aurora Biopharma CAR T-Cell Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Xyphos Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Xyphos Product Profiles, Application and Specification
-
Table Xyphos CAR T-Cell Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table AbbVie Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table AbbVie Product Profiles, Application and Specification
-
Table AbbVie CAR T-Cell Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Bellicum Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Bellicum Product Profiles, Application and Specification
-
Table Bellicum CAR T-Cell Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Adaptimmune Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Adaptimmune Product Profiles, Application and Specification
-
Table Adaptimmune CAR T-Cell Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Novartis Product Profiles, Application and Specification
-
Table Novartis CAR T-Cell Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Kite Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Kite Pharma Product Profiles, Application and Specification
-
Table Kite Pharma CAR T-Cell Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Ziopharm Oncology Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Ziopharm Oncology Product Profiles, Application and Specification
-
Table Ziopharm Oncology CAR T-Cell Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
